Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Hemosure® logo — The #1 iFOB Test in the US.

Hemosure®

The #1 iFOB Test in the US.

Founded 2003 United States Irwindale, United States 25 employees Food and Beverage, Manufacturing

General Information

Company Name Hemosure®
Founded Year 2003
Location United States Irwindale, United States +1
Employees 25
Industries Food and Beverage, Manufacturing
Social

Get notified when Hemosure® moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hemosure®

Hemosure® Inc. has been leading the field of clinical diagnostic test kits and medical devices since 2003. The company prides itself on the enduring success of its Fecal Occult Blood test (iFOB), maintaining its position as the #1 test in the US for nearly a decade, showcasing its quality and effectiveness. The recent introduction of the FDA cleared, Hemosure® Accu-Reader A 100 product line, an automated immunochemical Fecal Occult Blood diagnostic system, marks another significant milestone. This demonstrates the company's commitment to safety and accuracy through rigorous testing and evaluation. The automation provided by the Hemosure® Accu-Reader A 100 has the potential to enhance the standard of care in diagnosing gastrointestinal disorders by detecting occult blood in stool samples in just 5 minutes, boosting efficiency and reliability for healthcare professionals. Situated in Irwindale, California, the company's proximity to downtown Los Angeles enhances accessibility and collaboration with medical professionals and institutions in the area. Hemosure® Inc. is at the forefront of medical diagnostics, striving to contribute to the improvement of the quality of life for all.

Taxonomy: Clinical Diagnostic Test Kits, FDA Cleared, Automated Immunochemical Fecal Occult Blood Diagnostic System, Healthcare Efficiency, Gastrointestinal Disorders, Rapid Diagnostics, Medical Diagnostics, Quality of Life Improvement, Los Angeles Proximity, Medical Institutions Collaboration

No funding data available for Hemosure® yet.

Get notified when Hemosure® raises funding

Hemosure® Alternatives & Competitors

Hemosure® vs
GattaCo Inc.
GattaCo Inc. United States

Plasma at Your Fingertips(TM)

Series Unknown
6 employees
Health Care, Medical Devices
Hemosure® vs
T2 Biosystems
T2 Biosystems United States

Rapid detection of sepsis-causing pathogens

Post Ipo Equity
140 employees
Biotechnology, Health Care
Hemosure® vs
Caption Health
Caption Health United States

Acquired by GE HealthCare

Acquired
63 employees
AI, Health Care

FAQ About Hemosure®

The #1 iFOB Test in the US.
Hemosure® was founded in 2003.
Hemosure® is headquartered in Irwindale, United States.
Hemosure® operates in the following industries: Food and Beverage, Manufacturing.
Hemosure® has approximately 25 employees.
Top alternatives and competitors to Hemosure® include GattaCo Inc. , T2 Biosystems, Caption Health, Accu Reference Medical Lab, Optina Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hemosure® and GattaCo Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hemosure® and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy